Grupos de investigación

Publicaciones 2007-2009

Publicaciones anteriores

  1. “Pituitary adenylyl cyclase-activating polypeptide is an intrinsic regulator of Treg abundance and protects against experimental autoimmune encephalomyelitis”. Tan YV, Abad C, Lopez R, Dong H, Liu S, Lee A, Gomariz RP, Leceta J, Waschek JA. Proc Natl Acad Sci U S A. 2009 Feb 10;106(6):2012-7. PDF
  2. “Vasoactive intestinal peptide as a healing mediator in Crohn"s disease”. Arranz A, Abad C, Juarranz Y, Leceta J, Martinez C, Gomariz RP. Neuroimmunomodulation. 2008;15(1):46-53.
  3. “VIP reverses the expression profiling of TLR4-stimulated signaling pathway in rheumatoid arthritis synovial fibroblasts”. Arranz A, Gutiérrez-Cañas I, Carrión M, Juarranz Y, Pablos JL, Martínez C, Gomariz RP. Mol Immunol. 2008 Jun;45(11):3065-73.
  4. “Differential expression of vasoactive intestinal peptide and its functional receptors in human osteoarthritic and rheumatoid synovial fibroblasts”. Juarranz Y, Gutiérrez-Cañas I, Santiago B, Carrión M, Pablos JL, Gomariz RP. Arthritis Rheum. 2008 Apr;58(4):1086-95. PDF
  5. “VIP balances innate and adaptive immune responses induced by specific stimulation of TLR2 and TLR4”. Arranz A, Juarranz Y, Leceta J, Gomariz RP, Martínez C. Peptides. 2008 Jun;29(6):948-56.
  6. “Vasoactive intestinal peptide suppresses toll-like receptor 4 expression in macrophages via Akt1 reducing their responsiveness to lipopolysaccharide”. Arranz A, Androulidaki A, Zacharioudaki V, Martinez C, Margioris AN, Gomariz RP, Tsatsanis C. Mol Immunol. 2008 May;45(10):2970-80.
  7. “Vasoactive intestinal peptide regulates Th17 function in autoimmune inflammation”. Leceta J, Gomariz RP, Martinez C, Carrión M, Arranz A, Juarranz Y. Neuroimmunomodulation. 2007;14(3-4):134-8.
  8. “Immunoregulatory properties of vasoactive intestinal peptide in human T cell subsets: implications for rheumatoid arthritis”. Gutiérrez-Cañas I, Juarranz Y, Santiago B, Martínez C, Gomariz RP, Pablos JL, Leceta J. Brain Behav Immun. 2008 Mar;22(3):312-7.
  9. “Regulation of TLR expression, a new perspective for the role of VIP in immunity”. Gomariz RP, Arranz A, Juarranz Y, Gutierrez-Cañas I, Garcia-Gomez M, Leceta J, Martínez C. Peptides. 2007 Sep;28(9):1825-32.